![Antitumor-photosensitizer-5-DataSheet-生命科學(xué)試劑-MCE_第1頁(yè)](http://file4.renrendoc.com/view10/M01/12/15/wKhkGWWKOaCAHZSbAAKl464d0vM293.jpg)
![Antitumor-photosensitizer-5-DataSheet-生命科學(xué)試劑-MCE_第2頁(yè)](http://file4.renrendoc.com/view10/M01/12/15/wKhkGWWKOaCAHZSbAAKl464d0vM2932.jpg)
![Antitumor-photosensitizer-5-DataSheet-生命科學(xué)試劑-MCE_第3頁(yè)](http://file4.renrendoc.com/view10/M01/12/15/wKhkGWWKOaCAHZSbAAKl464d0vM2933.jpg)
下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Hotline:400-820-3792Inhibitors ? ScreeningLibraries ? Proteinswww.MedChemEAntitumorphotosensitizer-5Cat.No.:HY-163034分子式:C??H??F??N??O?P?RuS分子量:1289.04作用靶點(diǎn):Apoptosis;ReactiveOxygenSpecies作用通路:Apoptosis;Immunology/Inflammation;MetabolicEnzyme/Protease;NF-κB儲(chǔ)存方式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY生物活性Antitumorphotosensitizer-5(Ru2)是一種有效靶向腫瘤線粒體的光敏劑,對(duì)A549細(xì)胞光毒性的IC50為0.3μM。在460nm光照下,Antitumorphotosensitizer-5誘導(dǎo)活性氧的生成和NADH的耗竭,進(jìn)而導(dǎo)致線粒體損傷并活化caspase-3,誘導(dǎo)細(xì)胞凋亡并抑制細(xì)胞遷移。Antitumorphotosensitizer-5具有阻止惡性腫瘤生長(zhǎng)的潛力,因此顯示出應(yīng)用于光動(dòng)力治療的潛力[1]。IC50&TargetNicotinamideadeninedinucleotide(NADH)[1]體外研究Antitumorphotosensitizer-5(10μM,4h)causesasignificantincrease(32.08-fold)influorescencesignalinA549cells(biotinreceptor-positive)whileinducingBHKcells(biotinreceptor-negative)toexhibitnegligiblefluorescenceincrease(7.35-fold)[1].Antitumorphotosensitizer-5(0.391-100μM,24h)exhibitsphototoxicityinbothBHKcellsandA549cellsandrevealsminimalcytotoxicityintheabsenceoflightwithover75%cellviabilityunder100μM[1].Antitumorphotosensitizer-5(10μM,4h)hasaPearsoncolocalizationcoefficientof0.87withthemitochondrialprobeMito-TrackerGreen[1].Antitumorphotosensitizer-5(0.15-0.6μM,24h)with460nmlightirradiationfor15minexhibitsaconcentration-dependentreductioninthemitochondrialmembranepotentialprobefluorescenceintensityratiowhichindicatedthemitochondrialdamage,whiletheROSprobefluorescenceintensityexhibitsaconcentration-dependentincrease,indicatingeffectivegenerationofROS[1].Antitumorphotosensitizer-5(0.15-0.6μM,24h)causestheoccurrenceofapoptosisinA549cellsafterlightirradiation,whiletheapoptosislevelisvirtuallyunchangedunderdarkcondition,lightconditionalsocausestheincreaseofactivatedcaspase-3,themigrationanddamageofDNAandthereductionofcellularNADHcontent[1].Antitumorphotosensitizer-5(0.15-0.6μM,24h/48h)inhibitsthecellmigrationofA549cellsunder460nm1/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemElight[1].CellViabilityAssay[1]CellLine:BHK,A549Concentration:0.195,0.391,0.781,1.563,3.125,6.250,12.5,25,50,100μMIncubationTime:4hindark+15mininlightordark+20hindarkResult:ExhibitedphototoxicityinbothBHKcellsandA549cells,butwasmorephototoxicinA549cells(A549cellviability<40%under0.391μMwhileBHKcellviability<40%under6.25μM),revealedminimalcytotoxicityintheabsenceoflightwithover75%cellviabilityunder100μM.ApoptosisAnalysis[1]CellLine:A549Concentration:0.15,0.3,0.6μMIncubationTime:4hindark+15mininlightordark+20hindarkResult:IncreasedthepercentageofearlyandlateapoptoticcellsinA549inaconcentration-dependentmannerunderthe460nmlightcondition.Conversely,underdarkconditions,thepercentageofearlyandlateapoptoticcellsintreatedA549cellsremainedvirtuallyunchanged.CellMigrationAssay[1]CellLine:A549Concentration:0.15,0.3,0.6μMIncubationTime:4hindark+15mininlightordark+20h/44hindarkResult:Displayedasignificantconcentration-dependentinhibitionofwoundhealinginA549cellsunder460nmlightcomparedtocellskeptinthedark.體內(nèi)研究Antitumorphotosensitizer-5(10mg/kg,i.tu.foronce,24d)remarkablysuppressesthetumorgrowthafter460nmlightirradiation,anddoesn'tcausesevereadverseeffectsonnormalorgans[1].AnimalModel:BALB/cnudefemalemice(6–8weeksold),HumanlungadenocarcinomaepithelialA549cells[1]Dosage:10mg/kgAdministration:intratumoralinjection(i.tu.)foronce2/3 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemEResult: Suppressedthetumorgrowthremarkablyinthelightgroupwhiletumorsinthedarkorcontrolgroupsgrowrapidlyduringthesameperiod.Causedsevereapoptosisanddisruptionofthetumorstructureinthetumoroflightgroupwhilethetumorsintheothergroupshowednoobvioustissuedamage,normalorganssuchastheheart,liver,spleen,lung,andkidneydidnotexhibitsignificantpathologicalabnormalitiesorinflammatorylesions.REFERENCESGuoqiangShao,etal.Biotin-conjugatedRu(II)complexeswithAIEcharacteristicsasmitochondria-targetedphotosensitizersforenhancingphotodynamictherapybydisruptingcellularredoxbalance.EuropeanJournalofMedicinalChemistry.2023,Vol
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年度建筑園林景觀施工合同
- 2025年度租賃房屋終止協(xié)議(含租期提前終止條件)
- 2025年度股權(quán)激勵(lì)項(xiàng)目投資顧問(wèn)合同范本
- 2025年度內(nèi)部承包技術(shù)創(chuàng)新合作協(xié)議
- 2025年度聚苯板行業(yè)信息共享與交流合作合同
- 2025年度健康醫(yī)療公司股東股權(quán)轉(zhuǎn)讓與健康管理服務(wù)合同
- 女方離婚協(xié)議書范本(2025年度財(cái)產(chǎn)分割與子女撫養(yǎng))-@-1
- 現(xiàn)代辦公設(shè)備的維護(hù)與使用指南
- 電力系統(tǒng)智能化運(yùn)維及降低成本路徑探索
- 現(xiàn)代服務(wù)產(chǎn)業(yè)在商業(yè)領(lǐng)域的創(chuàng)新應(yīng)用與發(fā)展策略
- 2024年山東水利職業(yè)學(xué)院高職單招職業(yè)技能測(cè)驗(yàn)歷年參考題庫(kù)(頻考版)含答案解析
- 遼寧省名校聯(lián)盟2025年高三1月份聯(lián)合考試 語(yǔ)文試卷(含答案詳解)
- 25版六年級(jí)寒假特色作業(yè)
- 浙江省杭州市9+1高中聯(lián)盟2025屆高三一診考試英語(yǔ)試卷含解析
- 旅游行業(yè)智慧旅游營(yíng)銷策略與方案
- 《應(yīng)收培訓(xùn)》課件
- 2024年醫(yī)療器械經(jīng)營(yíng)質(zhì)量管理規(guī)范培訓(xùn)課件
- 中華人民共和國(guó)學(xué)前教育法-知識(shí)培訓(xùn)
- 2024統(tǒng)編版初中八年級(jí)語(yǔ)文上冊(cè)第五單元:大單元整體教學(xué)設(shè)計(jì)
- 小記者新聞寫作培訓(xùn)
- 【《智慧城市建設(shè)中電子政務(wù)建設(shè)問(wèn)題及完善策略一以瀘州市為例》9000字(論文)】
評(píng)論
0/150
提交評(píng)論